| |
| |
|
| Insider
Information: |
Heffernan Michael Thomas |
| Relationship: |
|
| City: |
Cary |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
115,623 |
|
|
Indirect Shares
|
163,043 |
|
|
| Direct
Value |
$2,064,363 |
|
|
|
Indirect Value
|
$5,413,028 |
|
|
| Total
Shares |
278,666 |
|
|
| Total
Value |
$7,477,391 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Collegium Pharmaceutical, Inc |
COLL |
Director |
2024-05-16 |
45,508 |
2016-04-05 |
163,043 |
Premium* |
|
|
Keryx Biopharmaceuticals Inc |
KERX |
Director |
2018-12-12 |
0 |
2017-06-09 |
0 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
|
2021-06-02 |
48,586 |
2018-12-12 |
0 |
Premium* |
|
|
Trevi Therapeutics, Inc. |
TRVI |
Director |
2019-05-09 |
6,351 |
2019-05-09 |
0 |
Premium* |
|
|
Biohaven Ltd. |
BHVN |
|
2022-10-03 |
15,178 |
2022-10-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
82 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2017-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
610,555 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2018-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
593,987 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2018-06-11 |
4 |
S |
$25.28 |
$2,450,719 |
D/D |
(96,943) |
441,750 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2022-12-13 |
4 |
AS |
$22.16 |
$3,582,984 |
D/D |
(161,687) |
28,023 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2022-12-13 |
4 |
OE |
$14.57 |
$2,441,404 |
D/D |
161,687 |
189,710 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2020-01-21 |
4 |
OE |
$5.73 |
$1,578,403 |
D/D |
275,463 |
402,086 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2020-01-21 |
4 |
AS |
$21.84 |
$6,476,863 |
D/D |
(295,287) |
106,799 |
0 |
% |
|
82 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
